Trial · NCT06882785
Registered outcomes35
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 35
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in Positive and Negative Syndrome Scale (PANSS) total score | At week 5 | Double-Blind Part |
| Primary | Number of participants with treatment-emergent adverse events (TEAEs) | At Week 52 from OLE baseline | Open-label extension (OLE) Part |
| Secondary | Change from baseline in PANSS positive score | At week 5 | Double-blind Part |
| Secondary | Change from baseline in PANSS negative score | At week 5 | Double-blind Part |
| Secondary | Change from baseline in PANSS Negative Marder Factor score | At week 5 | Double-blind Part |
| Secondary | Change from baseline in Clinical Global Impressions-Severity (CGI-S) score | At week 5 | Double-blind Part |
| Secondary | The percentage of PANSS responders (a ≥ 30% change in PANSS total score) | At week 5 | Double-blind Part |
| Secondary | Number of participants wtih adverse events (AEs) | Up to day 35 | Double-blind Part |
| Secondary | Number of participants wtih adverse events of special interest (AESIs) | Up to week 57 | |
| Secondary | Number of participants with procholinergic symptoms | Up to week 57 | |
| Secondary | Number of participants with anticholinergic symptoms | Up to week 57 | |
| Secondary | Change from baseline in Simpson-Angus Scale (SAS) score | Up to day 35 | Double-blind Part |
| Secondary | Change from baseline in Barnes Akathisia Rating Scale (BARS) score | Up to day 35 | Double-blind Part |
| Secondary | Change from baseline in Abnormal Involuntary Movement Scale (AIMS) score | Up to day 35 | Double-blind Part |
| Secondary | Change from baseline in body weight | Up to day 35 | Double-blind Part |
| Secondary | Change from baseline in body mass index (BMI) | Up to day 35 | Double-blind Part |
| Secondary | Blood pressure (BP) sitting and standing after 2 minutes | Up to week 57 | |
| Secondary | Heart rate (HR) sitting and standing after 2 minutes | Up to week 57 | |
| Secondary | Number of participants wtih a change from baseline in hematology evaluations | Up to week 57 | |
| Secondary | Number of participants wtih a change from baseline in clinical chemistry evaluations | Up to week 57 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06882785/registered